Four IPOs and three SPACs submitted initial filings. Leading meat products producer Smithfield Foods (SFD) priced its downsized IPO below the range to raise $522 million at a $7.9 billion market cap.

Cyient DLM actively seeks assets that align with its strategic goals ... and we would be very happy to partner with them or even consider them as potential acquisition targets. A. We did an IPO about ...

Thursday’s IPO included the offering of 70 million shares of Class A common stock at an initial price of $25 per share. With a total initial market cap of $65 billion, Venture Global (VG ...

Cyient DLM reported a challenging quarter. While consolidated revenues grew 38% YoY, aligning with expectations, the growth was just 11% YoY excluding Altek. Adjusted EBITDA came in at ₹360 mn ...

Motilal Oswal has revised its earnings estimates for Cyient DLM The brokerage firm, Motilal Oswal has retained its “Buy” rating on Cyient DLM’s stock, setting a target price of Rs 700.

Shares of Cyient DLM plunged more than 14% on Wednesday following the electronic manufacturing services firm's disappointing December quarter results. The company's stock plummeted 14.11% on the NSE ...

Cyient DLM is aiming for 30% year-on-year (YoY) revenue growth in 2025-26 (FY26), aligning with the industry growth rate. CEO Anthony Montalbano expects earnings before interest, taxes, depreciation, ...

Cyient DLM reported an adjusted PAT of Rs 166 crore for the quarter. Revenue grew 38.4% YoY to Rs 4,442 crore, while adjusted EBITDA rose 21.9% YoY to Rs 359 crore. However, the EBITDA margin ...

Motilal Oswal Financial Services retained a ‘Buy’ rating on Cyient DLM, revising the stock's target price to Rs 7,500–Rs 8,000. However, the brokerage adjusted its earnings estimates downward by three ...

The IPO comes at a time when space stocks are rallying, with names like Rocket Lab USA (NASDAQ:RKLB) and Intuitive Machines (NASDAQ:LUNR) seeing double-digit gains since President Trump's ...

Shares of electronic manufacturing firm Cyient DLM took a significant hit for the second consecutive day, falling more than 12 percent on Wednesday following disappointing quarterly profit results.